• Something wrong with this record ?

Anticonvulsant and behavioral effects of muscimol in immature rats

P. Mareš, K. Tichá, A. Mikulecká,

. 2014 ; 1582 (-) : 227-36.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15023182

Potentiation of GABAergic inhibition is a mechanism of action of many antiepileptic drugs. The potential use of an agonist of GABAA receptors, muscimol, as an antiepileptic drug was studied in immature rats by assessing anticonvulsant activity and side effects on motor activities. Anticonvulsant action was tested in two models of seizures (pentetrazol-induced convulsions and cortical epileptic afterdischarges). Off target effect on motor performance was assessed in a battery of tests and in the open field in three age groups (12-, 18- and 25-day-old rats). Muscimol was administered in doses from 0.1 to 1mg/kg i.p. Only the 1 mg/kg dose exhibited marked anticonvulsant effect against pentetrazol-induced convulsions in 12- and 18-day-old rats, proconvulsant effect was observed in the second model in 18- and 25-day-old rats as prolongation of afterdischarges. Even the 0.5 mg/kg dose suppressed spontaneous locomotion and heavily compromised motor performance. The effect on motor activity was marked in the youngest group and decreased with age. Due to the low anticonvulsant potency and serious side effects, systemic administration of a competitive agonist of GABAA receptors in immature animals is not a promising strategy for new anticonvulsants.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023182
003      
CZ-PrNML
005      
20150729121500.0
007      
ta
008      
150709s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.brainres.2014.07.038 $2 doi
035    __
$a (PubMed)25084038
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mareš, Pavel $u Department of Developmental Epileptology, Institute of Physiology, Academy of Sciences, Czech Republic. Electronic address: maresp@biomed.cas.cz.
245    10
$a Anticonvulsant and behavioral effects of muscimol in immature rats / $c P. Mareš, K. Tichá, A. Mikulecká,
520    9_
$a Potentiation of GABAergic inhibition is a mechanism of action of many antiepileptic drugs. The potential use of an agonist of GABAA receptors, muscimol, as an antiepileptic drug was studied in immature rats by assessing anticonvulsant activity and side effects on motor activities. Anticonvulsant action was tested in two models of seizures (pentetrazol-induced convulsions and cortical epileptic afterdischarges). Off target effect on motor performance was assessed in a battery of tests and in the open field in three age groups (12-, 18- and 25-day-old rats). Muscimol was administered in doses from 0.1 to 1mg/kg i.p. Only the 1 mg/kg dose exhibited marked anticonvulsant effect against pentetrazol-induced convulsions in 12- and 18-day-old rats, proconvulsant effect was observed in the second model in 18- and 25-day-old rats as prolongation of afterdischarges. Even the 0.5 mg/kg dose suppressed spontaneous locomotion and heavily compromised motor performance. The effect on motor activity was marked in the youngest group and decreased with age. Due to the low anticonvulsant potency and serious side effects, systemic administration of a competitive agonist of GABAA receptors in immature animals is not a promising strategy for new anticonvulsants.
650    _2
$a věkové faktory $7 D000367
650    _2
$a zvířata $7 D000818
650    _2
$a antikonvulziva $x farmakologie $7 D000927
650    _2
$a mozek $x účinky léků $x růst a vývoj $x patofyziologie $7 D001921
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a elektroencefalografie $7 D004569
650    _2
$a epilepsie $x farmakoterapie $x patofyziologie $7 D004827
650    _2
$a pátrací chování $x účinky léků $x fyziologie $7 D005106
650    _2
$a agonisté receptorů GABA-A $x farmakologie $7 D058785
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pohybová aktivita $x účinky léků $x fyziologie $7 D009043
650    _2
$a muscimol $x farmakologie $7 D009118
650    _2
$a neuropsychologické testy $7 D009483
650    _2
$a pentylentetrazol $7 D010433
650    _2
$a potkani Wistar $7 D017208
650    _2
$a záchvaty $x farmakoterapie $x patofyziologie $7 D012640
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tichá, Kateřina $u Department of Developmental Epileptology, Institute of Physiology, Academy of Sciences, Czech Republic; Charles University, 2nd Medical Faculty, Prague, Czech Republic.
700    1_
$a Mikulecká, Anna $u Department of Developmental Epileptology, Institute of Physiology, Academy of Sciences, Czech Republic.
773    0_
$w MED00000841 $t Brain research $x 1872-6240 $g Roč. 1582, č. - (2014), s. 227-36
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25084038 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150729121546 $b ABA008
999    __
$a ok $b bmc $g 1083520 $s 906175
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 1582 $c - $d 227-36 $i 1872-6240 $m Brain research $n Brain Res $x MED00000841
LZP    __
$a Pubmed-20150709

Find record

Citation metrics

Archiving options